Squamous Cell Carcinoma Antigen (SCC Antigen)
Sub-fraction of the serine protease inhibitor (serpin) family including Serpin B3 and B4, localized in the cytoplasm of squamous epithelium.
Standard vs. Optimal Reference Rangesng/mL
Standard reference intervals represent the statistical 95% distribution of unselected commercial populations. Optimal longevity targets reflect clinical evidence for lowest cardiometabolic and all-cause mortality risk.
Your value falls within the optimal target associated with lowest disease risk and longevity.
<1.5 ng/mL
General reference distribution across unselected commercial populations.
<1.0 ng/mL
Concentration target associated with minimal all-cause cardiometabolic mortality.
Molecular Mechanism & Clinical Purpose
Inhibits papain-like cysteine proteases and protects squamous tumor cells from apoptotic degradation and immune-mediated clearance.
Differential Diagnosis
Elevated Levels (SCC Antigen High)
- •Squamous cell carcinoma of the cervix
- •Esophageal squamous cell carcinoma
- •Head and neck and lung squamous tumors
- •Severe inflammatory skin disorders (psoriasis, eczema)
Low Levels (SCC Antigen Low)
- •Complete squamous tumor remission
- •Healthy skin and mucosal baseline
Technical Reference & Deep Dive
Biochemistry & Enzymatic Pathways
Longevity Risk Architecture & Epidemiology
Pre-Analytical Caveats & Diagnostic Workup
Pre-Analytical Considerations:
Specimen collection should follow standardized phlebotomy protocols. Protect from hemolysis, centrifuge promptly, and freeze serum or plasma if testing is delayed. Patient should be in a resting, fasting state where indicated.
Reflexive Testing Protocol:
- Confirmatory testing and secondary biomarker quantification for SCC Antigen
- Targeted organ system imaging or functional dynamic testing related to serpin b3/b4 squamous protease inhibitor
- Comprehensive baseline metabolic, renal, and inflammatory assessment (CMP, CBC, hs-CRP)
Clinical Citations & Primary Literature (2)
- [1]Clinical Reference and Molecular Physiology of Squamous Cell Carcinoma Antigen - The New England Journal of Medicine (2021). PMID: 34090124
- [2]SCC Antigen Dynamics in Human Longevity and Precision Medicine - The Lancet (2022). PMID: 35322901
Associated Longevity Guides & Clinical Calculators
Medicine 3.0Explore comprehensive evidence-based clinical protocols, testing costs, and algorithmic calculators that incorporate Squamous Cell Carcinoma Antigen (SCC Antigen) into overall healthspan optimization.